Trial Outcomes & Findings for Assessing Fitting Guides in Alcon Multifocal Contact Lenses (NCT NCT03118934)
NCT ID: NCT03118934
Last Updated: 2018-09-26
Results Overview
The Investigator used a multi-focal contact lens fitting guide to determine which study lens to fit
COMPLETED
NA
188 participants
VIsit 1/Day 1
2018-09-26
Participant Flow
Subjects were recruited from 20 investigational sites located in the United States (14), United Kingdom (3), and Canada (3).
Of the 188 enrolled subjects, 6 were exited prior to trial fit. This reporting group includes all subjects randomized and trial fit, as randomized (182). Safety Analysis Set is reported as exposed.
Participant milestones
| Measure |
AOA MF - Alternative
Bilaterally (in both eyes) fitted using alternative fitting guide; lotrafilcon B multifocal contact lenses worn bilaterally for 10 ± 3 days
|
DACP MF - Alternative
Bilaterally fitted using alternative fitting guide; nelfilcon A multifocal contact lenses worn bilaterally for 10 ± 3 days
|
DT1 MF - Alternative
Bilaterally fitted using alternative fitting guide; delefilcon A multifocal contact lenses worn bilaterally for 10 ± 3 days
|
AOA MF - Current
Bilaterally fitted using current fitting guide; lotrafilcon B multifocal contact lenses worn bilaterally (in both eyes) for 10 ± 3 days
|
DACP MF - Current
Bilaterally fitted using current fitting guide; nelfilcon A multifocal contact lenses worn bilaterally for 10 ± 3 days
|
DT1 MF - Current
Bilaterally fitted using current fitting guide; delefilcon A multifocal contact lenses worn bilaterally for 10 ± 3 days
|
|---|---|---|---|---|---|---|
|
Overall Study
STARTED
|
34
|
31
|
34
|
29
|
29
|
25
|
|
Overall Study
Safety Analysis Set
|
34
|
29
|
34
|
29
|
26
|
25
|
|
Overall Study
COMPLETED
|
34
|
30
|
33
|
28
|
27
|
23
|
|
Overall Study
NOT COMPLETED
|
0
|
1
|
1
|
1
|
2
|
2
|
Reasons for withdrawal
| Measure |
AOA MF - Alternative
Bilaterally (in both eyes) fitted using alternative fitting guide; lotrafilcon B multifocal contact lenses worn bilaterally for 10 ± 3 days
|
DACP MF - Alternative
Bilaterally fitted using alternative fitting guide; nelfilcon A multifocal contact lenses worn bilaterally for 10 ± 3 days
|
DT1 MF - Alternative
Bilaterally fitted using alternative fitting guide; delefilcon A multifocal contact lenses worn bilaterally for 10 ± 3 days
|
AOA MF - Current
Bilaterally fitted using current fitting guide; lotrafilcon B multifocal contact lenses worn bilaterally (in both eyes) for 10 ± 3 days
|
DACP MF - Current
Bilaterally fitted using current fitting guide; nelfilcon A multifocal contact lenses worn bilaterally for 10 ± 3 days
|
DT1 MF - Current
Bilaterally fitted using current fitting guide; delefilcon A multifocal contact lenses worn bilaterally for 10 ± 3 days
|
|---|---|---|---|---|---|---|
|
Overall Study
Adverse Event
|
0
|
0
|
0
|
0
|
0
|
1
|
|
Overall Study
Physician Decision
|
0
|
0
|
0
|
0
|
0
|
1
|
|
Overall Study
Discontinued prior to exposure
|
0
|
1
|
1
|
1
|
2
|
0
|
Baseline Characteristics
Assessing Fitting Guides in Alcon Multifocal Contact Lenses
Baseline characteristics by cohort
| Measure |
AOA MF
n=63 Participants
Lotrafilcon B multifocal contact lenses worn bilaterally for 10 ± 3 days
|
DACP MF
n=55 Participants
Nelfilcon A multifocal contact lenses worn bilaterally for 10 ± 3 days
|
DT1 MF
n=59 Participants
Delefilcon A multifocal contact lenses worn bilaterally for 10 ± 3 days
|
Total
n=177 Participants
Total of all reporting groups
|
|---|---|---|---|---|
|
Age, Continuous
|
50.6 years
STANDARD_DEVIATION 6.9 • n=5 Participants
|
50.1 years
STANDARD_DEVIATION 6.7 • n=7 Participants
|
50.1 years
STANDARD_DEVIATION 6.7 • n=5 Participants
|
50.3 years
STANDARD_DEVIATION 6.7 • n=4 Participants
|
|
Sex: Female, Male
Female
|
51 Participants
n=5 Participants
|
46 Participants
n=7 Participants
|
52 Participants
n=5 Participants
|
149 Participants
n=4 Participants
|
|
Sex: Female, Male
Male
|
12 Participants
n=5 Participants
|
9 Participants
n=7 Participants
|
7 Participants
n=5 Participants
|
28 Participants
n=4 Participants
|
|
Race/Ethnicity, Customized
White
|
55 Participants
n=5 Participants
|
48 Participants
n=7 Participants
|
51 Participants
n=5 Participants
|
154 Participants
n=4 Participants
|
|
Race/Ethnicity, Customized
Black or African American
|
2 Participants
n=5 Participants
|
4 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
6 Participants
n=4 Participants
|
|
Race/Ethnicity, Customized
American Indian or Alaska Native
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
0 Participants
n=4 Participants
|
|
Race/Ethnicity, Customized
Asian
|
5 Participants
n=5 Participants
|
2 Participants
n=7 Participants
|
6 Participants
n=5 Participants
|
13 Participants
n=4 Participants
|
|
Race/Ethnicity, Customized
Native Hawaiian or Other Pacific Islander
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
0 Participants
n=4 Participants
|
|
Race/Ethnicity, Customized
Other
|
1 Participants
n=5 Participants
|
1 Participants
n=7 Participants
|
2 Participants
n=5 Participants
|
4 Participants
n=4 Participants
|
PRIMARY outcome
Timeframe: VIsit 1/Day 1Population: This analysis population includes all subjects randomized or assigned to study lenses as applicable, and exposed to study lenses including trial fit at Visit 1 (Full Analysis Set).
The Investigator used a multi-focal contact lens fitting guide to determine which study lens to fit
Outcome measures
| Measure |
Alternative
n=198 Eyes
Bilaterally fitted with trial lenses using the alternative fitting guide
|
Current
n=166 Eyes
Bilaterally fitted with trial lenses using the current fitting guide
|
|---|---|---|
|
Mean Number of Trial Lenses Needed to Fit Each Eye
|
1.2 lenses
Standard Deviation 0.5
|
1.4 lenses
Standard Deviation 0.5
|
Adverse Events
AOA MF Ocular
AOA MF Nonocular
DACP MF Ocular
DACP MF Nonocular
DT1 MF Ocular
DT1 MF Nonocular
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Head, CDMA Vision Care Franchise
Alcon, A Novartis Division
Results disclosure agreements
- Principal investigator is a sponsor employee Sponsor reserves the right of prior review of any publication or presentation of information related to the study.
- Publication restrictions are in place
Restriction type: OTHER